Get the Daily Brief
Latest Biotech News
Lila Sciences Nears $300M Fundraise for AI-Powered Scientific Discovery
AI startup Lila Sciences is closing in on a Series A funding round exceeding $300 million to advance its autonomous scientific research platform. The company aims to develop 'scientific...
Tumor Microenvironment Dynamics Under Neoadjuvant Therapy in Breast Cancer
A recent study utilizing single-cell and spatial omics technologies reveals the complex cellular interactions within the breast cancer tumor microenvironment (TME) during neoadjuvant treatment....
New Blood Test Detects Brain Worm Infections in Moose and Elk
Scientists have developed a novel antibody-based blood test capable of early diagnosis of infections caused by parasitic brain worms in moose and elk populations. This diagnostic tool promises...
Study Links FBXW11 Protein to Tumor Suppression in Liver Cancer
Researchers discovered the FBXW11 protein facilitates ubiquitination of YB1, a key factor in hepatocarcinoma growth suppression. This novel molecular mechanism opens potential therapeutic pathways...
Soil Metagenomics Unlocks New Antibiotic Candidates
Researchers at Rockefeller University have developed a long-read DNA sequencing approach that extracts large DNA fragments directly from soil. This method circumvents the need for culturing...
Novo Nordisk Cuts 9,000 Jobs Amid Market Challenges
Novo Nordisk revealed plans to reduce its global workforce by approximately 11.5%, cutting about 9,000 jobs to sharpen its focus on growth areas like diabetes and obesity. Despite strong revenues...
Biosimilar Adoption Faces Market and Pipeline Hurdles
Despite FDA approval of 84 biosimilars with 67 available to patients, adoption remains uneven with average market shares around 40%. The Biosimilars Council highlights barriers including pharmacy...
Exact Sciences Launches MCED Test Cancerguard
Exact Sciences has launched Cancerguard, a multi-cancer early detection (MCED) blood test designed to identify over 50 cancer types by detecting circulating tumor DNA and associated proteins....
AI Startup Lila Sciences Nears $300M Fundraise
Lila Sciences, an AI-driven company aiming to build ‘scientific superintelligence,’ is reportedly closing a Series A funding round exceeding $300 million. The oversubscribed mega-round will...
Sapio Sciences and Ultima Genomics Integrate Tech Platforms
Sapio Sciences and Ultima Genomics have entered a strategic partnership to combine Sapio's AI-powered lab informatics with Ultima's high-throughput, low-cost sequencing technology. The...
FDA’s Covid Vaccine Safety Data Spurs Debate
FDA officials plan to present data at an upcoming CDC advisory committee meeting linking Covid vaccines to 25 child deaths, based on Vaccine Adverse Event Reporting System (VAERS) data. Experts...
Advances in Cancer Immunotherapy Targeting PD-L1
Researchers have highlighted innovative strategies using PD-L1 siRNA to disrupt tumor immune evasion and enhance immunotherapy efficacy. By silencing PD-L1 expression, this approach reinvigorates...
Next-Gen Sequencing Transforms Viral Detection in Biologics
Next-generation sequencing (NGS) is emerging as a powerful alternative to traditional viral detection methods for biologics manufacturing. Offering rapid, broad, and sensitive virus...
Biopharma Financing and Market Performance Surge to Record Levels
Biopharma dealmaking surged to an unprecedented $185 billion through August 2025, reflecting a near 36% increase compared with 2024. Alongside robust financing activity, public and private...
Promising Therapeutics Advance in Neurodegenerative and Rare Diseases
Recent clinical data highlight advances in treatments for Alzheimer’s and Duchenne muscular dystrophy. Remynd NV reported positive Phase IIa trial results for its REM-127 candidate in Alzheimer's,...
Novel Genomic and AI Partnerships Enhance Biomedical Research Capacities
Ultima Genomics and Sapio Sciences announced a strategic partnership integrating Sapio's AI-powered informatics with Ultima’s high-throughput sequencing platforms, aiming to streamline multiomics...
Advanced Sequencing Technologies Expand Large-Scale Genomics Potential
MGI introduced their next-generation sequencer T7+ which offers up to 14Tb of high-quality data in 24 hours, addressing the longstanding speed versus throughput tradeoff in genomics. This...
Emerging Cancer Research Illuminates Tumor Microenvironment and Immune Modulation
Cutting-edge studies are elucidating the complex biology of cancer progression and therapy resistance. Research mapping tumor microenvironment dynamics in breast cancer using single-cell and...
Breakthroughs in Microbial Genomics Reveal New Antibiotics and Environmental Insights
Rockefeller University scientists leveraged terabase-scale long-read sequencing of soil metagenomes to reconstruct hundreds of complete bacterial genomes from uncultivated microbes, leading to...
FDA and Regulatory Environment Faces Controversies and Shifts
The FDA denied reports suggesting plans to abandon certain advisory committee meetings, reaffirming ongoing review processes amid scrutiny over Covid vaccine safety data linking shots to child...